4.6 Article

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 167, 期 6, 页码 2904-2911

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2012.07.018

关键词

Biomarkers; Cardiovascular risk; C-reactive protein; Framingham Risk Score; Soluble urokinase plasminogen activator receptor

资金

  1. Danish Heart Foundation
  2. Danish Medical Association Research Fund/Volten
  3. Danish Pharmaceutical Association
  4. Lundbeck Foundation
  5. Novo Nordisk Foundation
  6. Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish

向作者/读者索取更多资源

Background: The inflammatory biomarkers soluble urokinase plasminogen activator receptor (suPAR) and C-reactive protein (CRP) independently predict cardiovascular disease (CVD). The prognostic implications of suPAR and CRP combined with Framingham Risk Score (FRS) have not been determined. Methods: From 1993 to 1994, baseline levels of suPAR and CRP were obtained from 2315 generally healthy Danish individuals (mean [SD] age: 53.9 [10.6] years) who were followed for the composite outcome of ischemic heart disease, stroke and CVD mortality. Results: During a median follow-up of 12.7 years, 302 events were recorded. After adjusting for FRS, women with suPAR levels in the highest tertile had a 1.74-fold (95% confidence interval [CI]: 1.08-2.81, p=0.027) and men a 2.09-fold (95% CI: 1.37-3.18, p<0.001) increase in risk compared to the lowest tertile. Including suPAR and CRP together resulted in stronger risk prediction with a 3.30-fold (95% CI: 1.36-7.99, p<0.01) increase for women and a 3.53-fold (1.78-7.02, p<0.001) increase for men when both biomarkers were in the highest compared to the lowest tertile. The combined extreme tertiles of suPAR and CRP reallocated individuals predicted to an intermediate 10-year risk of CVD of 10-20% based on FRS, to low (<10%) or high (>20%) risk categories, respectively. This was reflected in a significant improvement of C statistics for men (p=0.034) and borderline significant for women (p=0.054), while the integrated discrimination improvement was highly significant (P <= 0.001) for both genders. Conclusions: suPAR provides prognostic information of CVD risk beyond FRS and improves risk prediction substantially when combined with CRP in this setting. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据